These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 12077012)
21. A non-invasive selective assessment of type I fibre mitochondrial function using 31P NMR spectroscopy. Evidence for impaired oxidative phosphorylation rate in skeletal muscle in patients with chronic heart failure. van der Ent M; Jeneson JA; Remme WJ; Berger R; Ciampricotti R; Visser F Eur Heart J; 1998 Jan; 19(1):124-31. PubMed ID: 9503185 [TBL] [Abstract][Full Text] [Related]
22. Contribution of specific skeletal muscle metabolic abnormalities to limitation of exercise capacity in patients with chronic heart failure: a phosphorus 31 nuclear magnetic resonance study. Chati Z; Zannad F; Robin-Lherbier B; Escanye JM; Jeandel C; Robert J; Aliot E Am Heart J; 1994 Oct; 128(4):781-92. PubMed ID: 7942449 [TBL] [Abstract][Full Text] [Related]
23. A relationship between impaired fetal growth and reduced muscle glycolysis revealed by 31P magnetic resonance spectroscopy. Taylor DJ; Thompson CH; Kemp GJ; Barnes PR; Sanderson AL; Radda GK; Phillips DI Diabetologia; 1995 Oct; 38(10):1205-12. PubMed ID: 8690173 [TBL] [Abstract][Full Text] [Related]
24. Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity. Tartaglia MC; Chen JT; Caramanos Z; Taivassalo T; Arnold DL; Argov Z Muscle Nerve; 2000 Feb; 23(2):175-81. PubMed ID: 10639607 [TBL] [Abstract][Full Text] [Related]
25. Mitochondrial dysfunction in myotonic dystrophy type 1. Gramegna LL; Giannoccaro MP; Manners DN; Testa C; Zanigni S; Evangelisti S; Bianchini C; Oppi F; Poda R; Avoni P; Lodi R; Liguori R; Tonon C Neuromuscul Disord; 2018 Feb; 28(2):144-149. PubMed ID: 29289451 [TBL] [Abstract][Full Text] [Related]
26. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study. Khushu S; Rana P; Sekhri T; Sripathy G; Tripathi RP Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062 [TBL] [Abstract][Full Text] [Related]
27. High-energy phosphate metabolism in the exercising muscle of patients with peripheral arterial disease. Schocke M; Esterhammer R; Greiner A Vasa; 2008 Aug; 37(3):199-210. PubMed ID: 18690587 [TBL] [Abstract][Full Text] [Related]
28. Bioenergetics of skeletal muscle in mitochondrial myopathy. Taylor DJ; Kemp GJ; Radda GK J Neurol Sci; 1994 Dec; 127(2):198-206. PubMed ID: 7707079 [TBL] [Abstract][Full Text] [Related]
29. Do dermatomyositis and polymyositis affect similar thigh muscles? A comparative MRI-based study. Pipitone N; Notarnicola A; Levrini G; Spaggiari L; Scardapane A; Iannone F; Lapadula G; Pattacini P; Zuccoli G; Salvarani C Clin Exp Rheumatol; 2016; 34(6):1098-1100. PubMed ID: 27991408 [TBL] [Abstract][Full Text] [Related]
30. Acidosis inhibits oxidative phosphorylation in contracting human skeletal muscle in vivo. Jubrias SA; Crowther GJ; Shankland EG; Gronka RK; Conley KE J Physiol; 2003 Dec; 553(Pt 2):589-99. PubMed ID: 14514869 [TBL] [Abstract][Full Text] [Related]
31. MRI and MRS of the skeletal muscle. Träber F; Kaiser WA; Reiser MF; Nägele M Bildgebung; 1992 Sep; 59(3):156-8. PubMed ID: 1422001 [TBL] [Abstract][Full Text] [Related]
32. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Alexanderson H; Stenström CH; Jenner G; Lundberg I Scand J Rheumatol; 2000; 29(5):295-301. PubMed ID: 11093595 [TBL] [Abstract][Full Text] [Related]
33. Abnormal lactate levels in patients with polymyositis and dermatomyositis: the benefits of a specific rehabilitative program. Bertolucci F; Neri R; Dalise S; Venturi M; Rossi B; Chisari C Eur J Phys Rehabil Med; 2014 Apr; 50(2):161-9. PubMed ID: 23820876 [TBL] [Abstract][Full Text] [Related]
34. Phosphorus magnetic resonance spectroscopy in cluster headache. Montagna P; Lodi R; Cortelli P; Pierangeli G; Iotti S; Cevoli S; Zaniol P; Barbiroli B Neurology; 1997 Jan; 48(1):113-8. PubMed ID: 9008505 [TBL] [Abstract][Full Text] [Related]
35. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. De Feyter HM; van den Broek NM; Praet SF; Nicolay K; van Loon LJ; Prompers JJ Eur J Endocrinol; 2008 May; 158(5):643-53. PubMed ID: 18426822 [TBL] [Abstract][Full Text] [Related]
36. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. Kemp GJ; Meyerspeer M; Moser E NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042 [TBL] [Abstract][Full Text] [Related]
37. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Scheuermann-Freestone M; Madsen PL; Manners D; Blamire AM; Buckingham RE; Styles P; Radda GK; Neubauer S; Clarke K Circulation; 2003 Jun; 107(24):3040-6. PubMed ID: 12810608 [TBL] [Abstract][Full Text] [Related]
38. Oxidative capacity and ageing in human muscle. Conley KE; Jubrias SA; Esselman PC J Physiol; 2000 Jul; 526 Pt 1(Pt 1):203-10. PubMed ID: 10878112 [TBL] [Abstract][Full Text] [Related]
39. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Lodi R; Schapira AH; Manners D; Styles P; Wood NW; Taylor DJ; Warner TT Ann Neurol; 2000 Jul; 48(1):72-6. PubMed ID: 10894218 [TBL] [Abstract][Full Text] [Related]
40. A metabolism study of human masseter muscle by 31P magnetic resonance spectroscopy during long periods of exercise and recovery. Sappey-Marinier D; Dheyriat A; Lissac M; Frutoso J; Mallet JJ; Bonmartin A Eur J Oral Sci; 1998 Feb; 106(1):552-8. PubMed ID: 9527354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]